Comparative susceptibility of Gemella morbillorum to 13 antimicrobial agents

Ellie Jc Goldstein; C Vreni Merriam; Marina C Claros; Diane M Citron

doi:10.1016/j.anaerobe.2022.102573

Comparative susceptibility of Gemella morbillorum to 13 antimicrobial agents

Anaerobe. 2022 Jun:75:102573. doi: 10.1016/j.anaerobe.2022.102573. Epub 2022 Apr 18.

Authors

Ellie Jc Goldstein¹, C Vreni Merriam², Marina C Claros², Diane M Citron²

Affiliations

¹ R M Alden Research Laboratory, Santa Monica, CA, 90404, USA. Electronic address: [email protected].
² R M Alden Research Laboratory, Santa Monica, CA, 90404, USA.

PMID: 35439642
DOI: 10.1016/j.anaerobe.2022.102573

Abstract

The in vitro activity of 13 antimicrobials against clinical isolates of Gemella morbillorum showed good susceptibility to clindamycin, all beta-lactams agents studied except cefoxitin (MIC_90, 4 μg/ml) and fluoroquinolones. There was 36% metronidazole resistance.

Keywords: Endocarditis; Gemella morbillorum; Metronidazole resistance.

MeSH terms

Anti-Bacterial Agents / pharmacology
Anti-Bacterial Agents / therapeutic use
Anti-Infective Agents* / pharmacology
Clindamycin
Gemella*
beta-Lactams

Substances

Anti-Bacterial Agents
Anti-Infective Agents
beta-Lactams
Clindamycin

Supplementary concepts

Gemella morbillorum